Search Results 1481-1490 of 20532 for hepatitis

1. Curriculum - Transplant Hepatology Fellowship (Florida) - Mayo Clinic College of Medicine & Science

   ... hepatitis, alcoholic liver disease, autoimmune hepatitis and hepatobiliary neoplasms. You develop skills in managing complications of chronic liver disease ...

2. Nausea and vomiting - Mayo Clinic

   Hepatitis C: How common is sexual transmission? Hepatitis C: What happens in end-stage liver disease? ... How do COVID-19 antibody tests differ from diagnostic ...

3. Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer - Mayo Clinic

   Has a known history of Hepatitis B (defined as Hepatitis B surface antigen [HBsAg] reactive) or known active Hepatitis C virus (defined as HCV RNA [qualitative] ...

4. Biliary atresia - Doctors and departments - Mayo Clinic

   oholic fatty liver disease, Cirrhosis, Autoimmune hepatitis, Alcoholic hepatitis, Hemochromatosis, Hepatic encephalopathy, Portal hypertension, Biliary atresia.

5. Emtricitabine, rilpivirine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

   Hepatitis B or C infection, history of or; Kidney failure, history of—Use with caution. May make these conditions worse. Kidney disease, end stage (who are ...

6. A Study to Evaluate CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma - Mayo Clinic

   If there is history of hepatitis C virus (HCV) infection, patients must have been treated and HCV viral load must be undetectable. Patient must have ...

7. Nevirapine (oral route) - Side effects & dosage - Mayo Clinic

   Hepatitis B or; Hepatitis C—Use with caution. May cause side effects to become worse. Liver disease, moderate or severe—Should not be used in patients with ...

8. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

   Patients who experienced a de novo or reactivated serious viral infection such as hepatitis B virus (HBV), hepatitis C virus (HCV), or HIV during Study GA29144.

9. A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

   Detectable viral infections (e.g. known HIV, known active hepatitis B or C). Participating Mayo Clinic locations. Study statuses change often. Please contact ...

10. A Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Terlipressin Treatment - Mayo Clinic

    Superimposed acute liver failure/injury due to factors other than alcoholic hepatitis, including acute viral hepatitis, drugs, medications (e.g., acetaminophen) ...